BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 34936172)

  • 1. Outcomes of dogs with thymoma treated with intensity modulated stereotactic body radiation therapy or non-modulated hypofractionated radiation therapy.
    Trageser E; Martin T; Hoaglund E; Leary D; LaRue S; Boss MK
    Vet Comp Oncol; 2022 Jun; 20(2):491-501. PubMed ID: 34936172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypofractionated radiation therapy in the treatment of canine thymoma: Retrospective study of eight cases.
    Goto S; Murakami M; Kawabe M; Iwasaki R; Heishima K; Sakai H; Mori T
    Vet Radiol Ultrasound; 2017 Sep; 58(5):613-620. PubMed ID: 28665494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiation therapy in the treatment of canine and feline thymomas: a retrospective study (1985-1999).
    Smith AN; Wright JC; Brawner WR; LaRue SM; Fineman L; Hogge GS; Kitchell BE; Hohenhaus AE; Burk RL; Dhaliwal RS; Duda LE
    J Am Anim Hosp Assoc; 2001; 37(5):489-96. PubMed ID: 11563450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Canine primary liver tumors treated with stereotactic body radiation therapy: A case series.
    Chan QYP; Morrow D; Lurie D
    Vet Radiol Ultrasound; 2024 Mar; 65(2):121-129. PubMed ID: 38279767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FEASIBILITY FOR USING HYPOFRACTIONATED STEREOTACTIC VOLUMETRIC MODULATED ARC RADIOTHERAPY (VMAT) WITH ADAPTIVE PLANNING FOR TREATMENT OF THYMOMA IN RABBITS: 15 CASES.
    Dolera M; Malfassi L; Mazza G; Urso G; Sala M; Marcarini S; Carrara N; Pavesi S; Finesso S; Kent MS
    Vet Radiol Ultrasound; 2016 May; 57(3):313-20. PubMed ID: 26748539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adaptive radiation therapy using weekly hypofractionation for thymoma treatment: A retrospective study of 10 rabbits.
    McCready JE; Poirier VJ; Fleck A; Darco J; Beaufrère HH
    Vet Comp Oncol; 2022 Sep; 20(3):559-567. PubMed ID: 35212142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes of 35 dogs with craniomaxillofacial osteosarcoma treated with stereotactic body radiation therapy.
    Altwal J; Lee BI; Boss MK; LaRue SM; Martin TW
    Vet Comp Oncol; 2024 Mar; 22(1):125-135. PubMed ID: 38246695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective Study of Stereotactic Body Radiation Therapy for Thymoma and Thymic Carcinoma: Therapeutic Effect and Toxicity Assessment.
    Hao XJ; Peng B; Zhou Z; Yang XQ
    Sci Rep; 2017 Oct; 7(1):13549. PubMed ID: 29051511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A retrospective analysis of stereotactic body radiation therapy for canine heart base tumors: 26 cases.
    Kruckman-Gatesy CR; Ames MK; Griffin LR; Boss MK; Rao S; Leary D; LaRue SM
    J Vet Cardiol; 2020 Feb; 27():62-77. PubMed ID: 32078943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and efficacy of stereotactic body radiation therapy (SBRT) for the treatment of canine thyroid carcinoma.
    Lee BI; LaRue SM; Seguin B; Griffin L; Prebble A; Martin T; Leary D; Boss MK
    Vet Comp Oncol; 2020 Dec; 18(4):843-853. PubMed ID: 32515526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dosimetric benefit of adaptive radiotherapy in the neoadjuvant management of canine and feline thymoma-An exploratory case series.
    Rohrer Bley C; Meier V; Schneider U
    Vet Comp Oncol; 2018 Sep; 16(3):324-329. PubMed ID: 29316134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retrospective study evaluating the efficacy of stereotactic body radiation therapy for the treatment of confirmed or suspected primary pulmonary carcinomas in dogs.
    Martin TW; LaRue SM; Griffin L; Leary D; Boss MK
    Vet Comp Oncol; 2023 Dec; 21(4):656-664. PubMed ID: 37620018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjuvant Proton Beam Therapy in the Management of Thymoma: A Dosimetric Comparison and Acute Toxicities.
    Parikh RR; Rhome R; Hug E; Tsai H; Cahlon O; Chon B; Goenka A
    Clin Lung Cancer; 2016 Sep; 17(5):362-366. PubMed ID: 27372386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcome of stereotactic body radiation for treatment of nasal and nasopharyngeal lymphoma in 32 cats.
    Reczynska AI; LaRue SM; Boss MK; Lee BI; Leary D; Pohlmann K; Griffin L; Lana S; Wormhoudt Martin T
    J Vet Intern Med; 2022 Mar; 36(2):733-742. PubMed ID: 35188694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcome of intensity-modulated radiation therapy-based stereotactic radiation therapy for treatment of canine nasal carcinomas.
    Fox-Alvarez S; Shiomitsu K; Lejeune AT; Szivek A; Kubicek L
    Vet Radiol Ultrasound; 2020 May; 61(3):370-378. PubMed ID: 32189433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiation treatment for thymoma in a dog.
    Hitt ME; Shaw DP; Hogan PM; Lennon VA; Amann JF
    J Am Vet Med Assoc; 1987 May; 190(9):1187-90. PubMed ID: 3583897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stereotactic body radiation therapy for heart-base tumors in six dogs.
    Magestro LM; Gieger TL; Nolan MW
    J Vet Cardiol; 2018 Jun; 20(3):186-197. PubMed ID: 29724584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Results of excision of thymoma in cats and dogs: 20 cases (1984-2005).
    Zitz JC; Birchard SJ; Couto GC; Samii VF; Weisbrode SE; Young GS
    J Am Vet Med Assoc; 2008 Apr; 232(8):1186-92. PubMed ID: 18412532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of radiotherapy in the treatment of lymphoma and thymoma.
    Meleo KA
    Vet Clin North Am Small Anim Pract; 1997 Jan; 27(1):115-29. PubMed ID: 9002171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes and adverse effects associated with stereotactic body radiation therapy in dogs with nasal tumors: 28 cases (2011-2016).
    Mayer MN; DeWalt JO; Sidhu N; Mauldin GN; Waldner CL
    J Am Vet Med Assoc; 2019 Mar; 254(5):602-612. PubMed ID: 30779620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.